申请人:Warner-Lambert Company
公开号:US04469868A1
公开(公告)日:1984-09-04
Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines and pharmaceutically acceptable salts are described. These compounds are antipsychotic agents. Methods for their preparation, pharmaceutical compositions which contain them and methods for using said compositions are also described.
描述了烷基咪唑[1,2-c]吡唑并[3,4-e]嘧啶以及药学上可接受的盐。这些化合物是抗精神病药物。还描述了它们的制备方法、含有它们的制药组合物以及使用这些组合物的方法。